Journal ArticleCancer Treat Rev · November 2024
Up to 40% of patients with non-small cell lung cancer (NSCLC) develop central nervous system (CNS) metastases. Current treatments for this subgroup of patients with advanced NSCLC include local therapies (surgery, stereotactic radiosurgery, and, less frequ ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · October 1, 2024
PURPOSE: To develop a novel deep ensemble learning model for accurate prediction of brain metastasis (BM) local control outcomes after stereotactic radiosurgery (SRS). METHODS AND MATERIALS: A total of 114 brain metastases (BMs) from 82 patients were evalu ...
Full textLink to itemCite
Journal ArticleJ Appl Clin Med Phys · June 2024
PURPOSE: For individual targets of single isocenter multi-target (SIMT) Stereotactic radiosurgery (SRS), we assess dose difference between the treatment planning system (TPS) and independent Monte Carlo (MC), and demonstrate persistence into the pre-treatm ...
Full textLink to itemCite
Journal ArticleAdv Radiat Oncol · June 2024
PURPOSE: Clinical and imaging surveillance of patients with brain metastases is important after stereotactic radiosurgery (SRS) because many will experience intracranial progression (ITCP) requiring multidisciplinary management. The prognostic significance ...
Full textLink to itemCite
Journal ArticleSci Data · May 15, 2024
Meningiomas are the most common primary intracranial tumors and can be associated with significant morbidity and mortality. Radiologists, neurosurgeons, neuro-oncologists, and radiation oncologists rely on brain MRI for diagnosis, treatment planning, and l ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · April 1, 2024
PURPOSE: The intracranial benefit of offering dual immune-checkpoint inhibition (D-ICPI) with ipilimumab and nivolumab to patients with melanoma or non-small cell lung cancer (NSCLC) receiving stereotactic radiosurgery (SRS) for brain metastases (BMs) is u ...
Full textLink to itemCite
Journal ArticleJ Neurooncol · March 2024
PURPOSE: During stereotactic radiosurgery (SRS) planning for brain metastases (BM), brain MRIs are reviewed to select appropriate targets based on radiographic characteristics. Some BM are difficult to detect and/or definitively identify and may go untreat ...
Full textLink to itemCite
Journal ArticleAdv Radiat Oncol · January 2024
PURPOSE: Genetic variants affecting the radiation response protein ataxia-telangiectasia mutated (ATM) have been associated with increased adverse effects of radiation but also with improved local control after conventional radiation therapy. However, it i ...
Full textLink to itemCite
Journal ArticleJ Radiosurg SBRT · 2024
PURPOSE: To investigate whether TP53 variants may be correlated with overall survival and local control following stereotactic radiosurgery (SRS) for brain metastases (BMs) from non-small cell lung cancer (NSCLC). METHODS: Patients undergoing an initial co ...
Link to itemCite
Journal ArticleZ Med Phys · September 7, 2023
BACKGROUND: Dosimetric validation of single isocenter multi-target radiosurgery plans is difficult due to conditions of electronic disequilibrium and the simultaneous irradiation of multiple off-axis lesions dispersed throughout the volume. Here we report ...
Full textLink to itemCite
Journal ArticleCancers (Basel) · April 24, 2023
Radiation necrosis, also known as treatment-induced necrosis, has emerged as an important adverse effect following stereotactic radiotherapy (SRS) for brain metastases. The improved survival of patients with brain metastases and increased use of combined s ...
Full textLink to itemCite
Journal ArticleJAMA Netw Open · April 3, 2023
IMPORTANCE: Clinical trials for metastatic malignant neoplasms are increasingly being extended to patients with brain metastases. Despite the preeminence of progression-free survival (PFS) as a primary oncologic end point, the correlation of intracranial p ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · March 1, 2023
PURPOSE: We sought to develop a computer-aided detection (CAD) system that optimally augments human performance, excelling especially at identifying small inconspicuous brain metastases (BMs), by training a convolutional neural network on a unique magnetic ...
Full textLink to itemCite
Journal ArticleAdv Radiat Oncol · 2023
PURPOSE: Hypofractionated stereotactic radiosurgery (HF-SRS) with or without surgical resection is potentially a preferred treatment for larger or symptomatic brain metastases (BMs). Herein, we report clinical outcomes and predictive factors following HF-S ...
Full textLink to itemCite
Journal ArticleAdv Radiat Oncol · 2023
PURPOSE: Existing brain metastasis prognostic models do not identify patients at risk of very poor survival after radiation therapy (RT). Identifying patient and disease risk factors for 30-day mortality (30-DM) after RT may help identify patients who woul ...
Full textLink to itemCite
Journal ArticleNeurooncol Adv · 2023
BACKGROUND: Laser interstitial thermal therapy (LITT) in the setting of post-SRS radiation necrosis (RN) for patients with brain metastases has growing evidence for efficacy. However, questions remain regarding hospitalization, local control, symptom contr ...
Full textLink to itemCite
Journal ArticleNeurooncol Adv · 2023
BACKGROUND: Primary central nervous system lymphoma (PCNSL) is an aggressive diffuse large B-cell lymphoma. Treatment approaches are historically associated with neurotoxicity, particularly with high-dose whole-brain radiotherapy (WBRT). We hypothesized th ...
Full textLink to itemCite
Journal ArticleCancers (Basel) · October 22, 2022
Stereotactic radiosurgery (SRS) is a standard of care for many patients with brain metastases. To optimize post-SRS surveillance, this study aimed to validate a previously published nomogram predicting post-SRS intracranial progression (IP). We identified ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · September 1, 2022
PURPOSE: Patients with lung cancer and brain metastases represent a markedly heterogeneous population. Accurate prognosis is essential to optimally individualize care. In prior publications, we described the graded prognostic assessment (GPA), but a GPA fo ...
Full textLink to itemCite
Journal ArticleCancers (Basel) · May 13, 2022
PURPOSE: We previously reported on the clinical outcomes of treating oligometastases with radiation using an elective simultaneous integrated boost technique (SIB), delivering higher doses to known metastases and reduced doses to adjacent bone or nodal bas ...
Full textLink to itemCite
Journal ArticleGlobal Spine J · April 2022
STUDY DESIGN: Retrospective cohort study. OBJECTIVE: The purpose of this study was to compare outcomes between different treatment modalities for metastatic disease with indeterminate instability (Spinal Instability Neoplastic Score [SINS] 7-12). METHODS: ...
Full textLink to itemCite
Journal ArticleCancers (Basel) · March 27, 2022
Numerous randomized trials have revealed that hyperthermia (HT) + radiotherapy or chemotherapy improves local tumor control, progression free and overall survival vs. radiotherapy or chemotherapy alone. Despite these successes, however, some individuals fa ...
Full textLink to itemCite
Journal ArticleAdv Radiat Oncol · 2022
PURPOSE: Atypical (World Health Organization [WHO] grade 2) and malignant (WHO grade 3) meningiomas have high rates of local recurrence, and questions remain about the role of adjuvant radiation therapy (RT) for patients with WHO grade 2 disease. These pat ...
Full textLink to itemCite
Journal ArticleOncotarget · 2022
IMPORTANCE: Radiation necrosis (RN) is a rare but serious adverse effect following treatment with radiation therapy. No standard of care exists for the management of RN, and efforts to prevent and treat RN are limited by a lack of insight into the pathomec ...
Full textLink to itemCite
Journal ArticleJ Radiosurg SBRT · 2022
PURPOSE: The epidural space is a frequent site of cancer recurrence after spine stereotactic radiosurgery (SSRS). This may be due to microscopic disease in the epidural space which is underdosed to obey strict spinal cord dose constraints. We hypothesized ...
Link to itemCite
Journal ArticleFront Oncol · 2022
BACKGROUND: There is a concern that HER2-directed systemic therapies, when administered concurrently with stereotactic radiosurgery (SRS), may increase the risk of radiation necrosis (RN). This study explores the impact of timing and type of systemic thera ...
Full textLink to itemCite
Journal ArticleNeurooncol Adv · 2022
BACKGROUND: Improved survival for patients with brain metastases has been accompanied by a rise in tumor recurrence after stereotactic radiotherapy (SRT). Laser interstitial thermal therapy (LITT) has emerged as an effective treatment for SRT failures as a ...
Full textLink to itemCite
Journal ArticlePract Radiat Oncol · 2022
PURPOSE: This guideline provides evidence-based recommendations for adults with isocitrate dehydrogenase (IDH)-mutant grade 2 and grade 3 diffuse glioma, as classified in the 2021 World Health Organization (WHO) Classification of Tumours. It includes indic ...
Full textLink to itemCite
ConferenceNeuro-Oncology · November 12, 2021
AbstractINTRODUCTIONVaccination with dendritic cells (DCs) fares poorly in primary and recurrent glioblastoma (GBM). Moreover, GBM vac ...
Full textOpen AccessLink to itemCite
ConferenceInternational journal of radiation oncology, biology, physics · November 2021
Purpose/objective(s)Improved survival for patients with brain metastases (BM) has been accompanied by a rise in tumor recurrence after stereotactic radiosurgery (SRS). Laser interstitial thermal therapy (LITT) has evolved as an effective treatment ...
Full textCite
ConferenceInternational journal of radiation oncology, biology, physics · November 2021
Purpose/objective(s)Radiation is increasingly used to treat oligometastatic patients (OM). Following metastasis directed radiation therapy, progression in nearby nodal basins or bones is common. We previously reported clinical outcomes of OM treat ...
Full textCite
Journal ArticleCNS Oncol · September 1, 2021
Purpose: To describe our population of primary brain tumor (PBT) patients, a subgroup of cancer patients whose intensive care unit (ICU) outcomes are understudied. Methods: Retrospective analysis of PBT patients admitted to an ICU between 2013 to 2018 for ...
Full textOpen AccessLink to itemCite
Journal ArticleCureus · June 2021
Brain metastases are a common complication for patients diagnosed with cancer. As stereotactic radiosurgery (SRS) becomes a more prevalent treatment option for patients with many brain metastases, further research is required to better characterize the abi ...
Full textOpen AccessLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · May 1, 2021
PURPOSE: Dosimetric and clinical predictors of radiation-induced optic nerve/chiasm neuropathy (RION) after single-fraction stereotactic radiosurgery (SRS) or hypofractionated (2-5 fractions) radiosurgery (fSRS) were analyzed from pooled data that were ext ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · May 1, 2021
PURPOSE: We sought to investigate the tumor control probability (TCP) of vestibular schwannomas after single-fraction stereotactic radiosurgery (SRS) or hypofractionated SRS over 2 to 5 fractions (fSRS). METHODS AND MATERIALS: Studies (PubMed indexed from ...
Full textLink to itemCite
Journal ArticleJ Neurosurg Spine · February 1, 2021
OBJECTIVE: Stereotactic body radiation therapy (SBRT) offers efficient, noninvasive treatment of spinal neoplasms. Single-fraction (SF) high-dose SBRT has a relatively narrow therapeutic window, while hypofractionated delivery of SBRT may have an improved ...
Full textLink to itemCite
Journal ArticleFront Oncol · 2021
OBJECTIVES: Standard 6-week and hypofractionated 3-week courses of adjuvant radiation therapy (RT) are both options for older patients with glioblastoma (GBM), but deciding the optimal regimen can be challenging. This analysis explores clinical factors ass ...
Full textOpen AccessLink to itemCite
Journal ArticleAdv Radiat Oncol · 2021
PURPOSE: To examine the effectiveness and safety of single-isocenter multitarget stereotactic radiosurgery using a volume-adapted dosing strategy in patients with 4 to 10 brain metastases. METHODS AND MATERIALS: Adult patients with 4 to 10 brain metastases ...
Full textLink to itemCite
Journal ArticleFront Oncol · 2021
Management of brain metastases is challenging, both because of the historically guarded prognosis and evolving, more efficacious treatment paradigms for metastatic cancer. This perspective addresses several of the important difficult questions that practit ...
Full textLink to itemCite
Journal ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology · November 2020
PurposeConventional wisdom has rendered patients with brain metastases ineligible for clinical trials for fear that poor survival could mask the benefit of otherwise promising treatments. Our group previously published the diagnosis-specific Grade ...
Full textCite
Journal ArticleNeuro Oncol · September 29, 2020
BACKGROUND: Breast cancer treatment is based on estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor receptor 2 (HER2). At the time of metastasis, receptor status can be discordant from that at initial diagnosis. The pu ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · June 1, 2020
PURPOSE: Brain metastases are a common sequelae of breast cancer. Survival varies widely based on diagnosis-specific prognostic factors (PF). We previously published a prognostic index (Graded Prognostic Assessment [GPA]) for patients with breast cancer wi ...
Full textLink to itemCite
Journal ArticleJ Appl Clin Med Phys · June 2020
PURPOSE: To characterize key plan quality metrics in multi-target stereotactic radiosurgery (SRS) plans treated using single-isocenter volumetric modulated arc therapy (VMAT) in comparison to dynamic conformal arc (DCA) plans treating single target. To inv ...
Full textLink to itemCite
Journal ArticleJ Neurooncol · April 2020
PURPOSE: Primary central nervous system lymphoma (PCNSL) is a subtype of non-Hodgkin's lymphoma that involves the brain, spinal cord, or leptomeninges, without evidence of systemic disease. This rare disease accounts for ~ 3% of all primary central nervous ...
Full textLink to itemCite
Journal ArticleCancer · April 1, 2020
Brain metastasis (BM), the most common adult brain tumor, develops in 20% to 40% of patients with late-stage cancer and traditionally are associated with a poor prognosis. The management of patients with BM has become increasingly complex because of new an ...
Full textLink to itemCite
Journal ArticleAdv Radiat Oncol · 2020
PURPOSE: Utilization of stereotactic radiosurgery (SRS) for brain metastases (BM) has increased, prompting reassessment of whole brain radiation therapy (WBRT). A pattern of care analysis of SRS and WBRT dose-fractionations was performed in patients presen ...
Full textLink to itemCite
Chapter · January 1, 2020
Single-fraction stereotactic radiosurgery (SF-SRS) is widely employed to safely and effectively treat small intracranial lesions. However, for large metastases or those in close proximity to critical structures, it can be difficult to obtain an acceptable ...
Full textCite
Journal ArticleClin Cancer Res · November 15, 2019
The incidence of brain metastases is increasing as cancer therapies improve and patients live longer, providing new challenges to the multidisciplinary teams that care for these patients. Brain metastatic cancer cells possess unique characteristics that al ...
Full textLink to itemCite
Journal ArticleCNS Oncol · November 1, 2019
Aim: Central neurocytoma (CN) is a rare WHO grade II central nervous system (CNS) tumor. This is an update on chemotherapeutic agents used in its treatment. Patients & methods: An institutional review board-approved, chart review of patients seen at our in ...
Full textOpen AccessLink to itemCite
Journal ArticleClin Transl Radiat Oncol · September 2019
BACKGROUND: Patients with gastrointestinal cancers and brain metastases (BM) represent a unique and heterogeneous population. Our group previously published the Diagnosis-Specific Graded Prognostic Assessment (DS-GPA) for patients with GI cancers (GI-GPA) ...
Full textLink to itemCite
Journal ArticleTransl Res · June 2019
The literature describing the prognosis of patients with gastrointestinal (GI) cancers and brain metastases (BM) is sparse. Our group previously published a prognostic index, the Graded Prognostic Assessment (GPA) for GI cancer patients with BM, based on 2 ...
Full textLink to itemCite
Journal ArticleJ Radiosurg SBRT · 2019
PURPOSE: To estimate the combined effect of setup uncertainty on optimal dosimetric margin by analyzing the dose distribution and biological effect in LINAC-based stereotactic radiosurgery (SRS) with dynamic conformal arc (DCA) technique. METHODS: SRS trea ...
Link to itemCite
Journal ArticleJ Cancer · 2019
Inflammatory breast cancer (IBC) is an understudied and aggressive form of breast cancer with a poor prognosis, accounting for 2-6% of new breast cancer diagnoses but 10% of all breast cancer-related deaths in the United States. Currently there are no ther ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Radiosurg SBRT · 2019
PURPOSE: Follow-up imaging after stereotactic radiosurgery (SRS) is crucial to identify salvageable brain metastases (BM) recurrence. As optimal imaging intervals are poorly understood, we sought to build a predictive model for time to intracranial progres ...
Link to itemCite
Journal ArticleJ Radiosurg SBRT · 2019
PURPOSE: Single-isocenter multi-target (SIMT) volumetric modulated arc therapy (VMAT) is primarily limited to linear accelerators utilizing 2.5 mm leaf width MLCs. We explore feasibility of applying this technique to linear accelerators utilizing MLCs with ...
Open AccessLink to itemCite
Journal ArticlePLoS One · 2019
PURPOSE: This study aimed to investigate the effectiveness of using delta-radiomics to predict overall survival (OS) for patients with recurrent malignant gliomas treated by concurrent stereotactic radiosurgery and bevacizumab, and to investigate the effec ...
Full textOpen AccessLink to itemCite
Journal ArticleFront Oncol · 2019
Myxopapillary ependymomas are a slow-growing, grade I type glial tumor in the lumbosacral region. More rarely, they can present as extradural, subcutaneous sacrococcygeal, or perisacral masses, and it is under these circumstances that they are more likely ...
Full textLink to itemCite
Journal ArticleNeuro Oncol · November 12, 2018
BACKGROUND: Brain metastases are a common complication of renal cell carcinoma (RCC). Our group previously published the Renal Graded Prognostic Assessment (GPA) tool. In our prior RCC study (n = 286, 1985-2005), we found marked heterogeneity and variation ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · July 15, 2018
PURPOSE: To identify prognostic factors, define evolving patterns of care, and the effect of targeted therapies in a larger contemporary cohort of renal cell carcinoma (RCC) patients with new brain metastases (BM). METHODS AND MATERIALS: A multi-institutio ...
Full textLink to itemCite
ConferenceNeurology · April 9, 2018
158
Objective: The purpose of this study is to analyze adult patients with pilocytic astrocytomas and to identify factors associated with recurrence and survival.
Background: Pilocytic astrocytomas (WHO grade I) represent the most common central nervous s ...
Link to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · February 1, 2018
PURPOSE: To propose contouring guidelines based on consensus contours generated by 10 international experts for cavity stereotactic radiosurgery (SRS), an emerging treatment option after surgical resection of brain metastases. No guidelines for contouring ...
Full textLink to itemCite
Journal ArticleJ Radiosurg SBRT · 2018
PURPOSE: To assess the response and predict the overall survival (OS) of recurrent malignant gliomas (MG) patients treated with concurrent BVZ/SRS using multi-modality MRI imaging and radiomics analysis.Methods and materials: SRS was delivered in a single ...
Link to itemCite
Journal ArticleTechnol Cancer Res Treat · December 2017
Our purpose was to investigate polymeric gels for use as a highly transparent radiotherapy bolus and determine the relevant physical and dosimetric properties. We first quantified tensile properties (maximum stress, strain, and Young modulus) for various p ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · November 15, 2017
PURPOSE: To update the Diagnosis-Specific Graded Prognostic Assessment (DS-GPA) for a markedly heterogeneous patient population, patients with melanoma and brain metastases, using a larger, more current cohort, including molecular markers. METHODS: The ori ...
Full textLink to itemCite
ConferenceNeuro-Oncology · November 1, 2017
RATE-36
INTRODUCTION
Primary central nervous system lymphoma (PCNSL) is a subtype of non-Hodgkin’s lymphoma that involves the brain, spinal cord or leptomeninges, without evidence of systemic disease. This rare disease accounts for ~3% of all primary centr ...
Full textLink to itemCite
Journal ArticleChinese Neurosurgical Journal · October 3, 2017
Background: While the optimal combination of whole-brain radiotherapy (WBRT), stereotactic radiosurgery (SRS) and surgical resection in the treatment of brain metastases, is controversial, the addition of SRS to surgical resction of solitary metastasis may ...
Full textCite
Journal ArticleNeuro Oncol · October 1, 2017
BACKGROUND: Stereotactic radiosurgery (SRS) offers excellent local control for brain metastases (BM) with low rates of toxicity. Radiation necrosis (RN) may occur after treatment and is challenging to distinguish from local recurrence (LR). We evaluated en ...
Full textLink to itemCite
Journal ArticleJ Neurooncol · September 2017
Forty years ago, adjuvant treatment of patients with GBM using fractionated radiotherapy following surgery was shown to substantially improve survival compared to surgery alone. However, even with the addition of temozolomide to radiotherapy, overall survi ...
Full textLink to itemCite
Journal ArticleTechnol Cancer Res Treat · August 2017
PURPOSE: To investigate the feasibility of using undersampled k-space data and an iterative image reconstruction method with total generalized variation penalty in the quantitative pharmacokinetic analysis for clinical brain dynamic contrast-enhanced magne ...
Full textLink to itemCite
Journal ArticleRadiat Res · August 2017
Breast cancer is the most common malignancy diagnosed among women and represents a heterogeneous group of subtypes. Radiation therapy is a critical component of treatment for breast cancer patients. However, little is known about radiation response among t ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · August 1, 2017
PURPOSE: Brain metastases are a common problem in patients with melanoma, but little is known about the effect of gene mutations on survival in these patients. METHODS AND MATERIALS: We created a retrospective multi-institutional database of 823 patients w ...
Full textLink to itemCite
Journal ArticleJAMA oncology · June 2017
ImportanceLung cancer is the leading cause of cancer-related mortality in the United States and worldwide. As systemic therapies improve, patients with lung cancer live longer and thus are at increased risk for brain metastases. Understanding how ...
Full textCite
ConferenceJournal of Clinical Oncology · May 20, 2017
2049 Background: Breast cancer brain metastasis (BCBM) is frequent in advanced disease, has limited therapies, and is associated with poor prognosis. Increased stromal tumor infiltrating lymphocytes (sTILs) are prognostic in trip ...
Full textCite
Journal ArticleNeuro Oncol · April 1, 2017
Stereotactic radiosurgery (SRS), typically administered in a single session, is widely employed to safely, efficiently, and effectively treat small intracranial lesions. However, for large lesions or those in close proximity to critical structures, it can ...
Full textLink to itemCite
Journal ArticleIEEE EMBS Int Conf Biomed Health Inform · February 2017
Standards for scoring adverse effects after radiation therapy (RT) is crucial for integrated, consistent, and accurate analysis of toxicity results at large scale and across multiple studies. This project aims to investigate the usage of the three most com ...
Full textLink to itemCite
Journal ArticleAdv Radiat Oncol · 2017
INTRODUCTION: Due to the neurocognitive side effects of whole brain radiation therapy (WBRT), stereotactic radiosurgery (SRS) is being used with increasing frequency. The use of SRS is expanding for patients with multiple (>4) brain metastases (BM). This s ...
Full textOpen AccessLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · October 1, 2016
PURPOSE: Lung cancer remains the most common cause of both cancer mortality and brain metastases (BM). The purpose of this study was to assess the effect of gene alterations and tyrosine kinase inhibition (TKI) on median survival (MS) and cause of death (C ...
Full textLink to itemCite
Journal ArticleMed Phys · October 2016
PURPOSE: The recent development of multifocal stereotactic radiosurgery (SRS) using a single isocenter volumetric modulated arc theory (VMAT) technique warrants a re-examination of the quality assurance (QA) tolerances for routine mechanical QA recommended ...
Full textLink to itemCite
ConferenceSupport Care Cancer · October 2016
BACKGROUND: In malignant glioma (MG) patients undergoing radiation therapy (RT) with concomitant temozolomide, chemoradiation-induced nausea and vomiting (cRINV) degrades quality of life (QoL) and reduces treatment adherence, which thereby potentially comp ...
Full textLink to itemCite
Journal ArticleOncoimmunology · July 2016
Brain metastases represent the most common type of brain tumor. These tumors offer a dismal prognosis and significantly impact quality of life for patients. Their capacity for central nervous system (CNS) invasion is dependent upon induced disruptions to t ...
Full textLink to itemCite
ConferencePract Radiat Oncol · 2016
OBJECTIVE: Our purpose was to address challenges associated with single-isocenter radiosurgery for multiple intracranial targets (SIRMIT) including increased sensitivity to rotational uncertainties (resulting from distance of the targets from isocenter) as ...
Full textLink to itemCite
Journal ArticlePract Radiat Oncol · 2016
PURPOSE: To present evidence-based guidelines for radiation therapy in treating glioblastoma not arising from the brainstem. METHODS AND MATERIALS: The American Society for Radiation Oncology (ASTRO) convened the Glioblastoma Guideline Panel to perform a s ...
Full textLink to itemCite
Journal ArticleWorld Neurosurg · April 2015
OBJECTIVE: Radiation-induced malignant gliomas (RIMGs) are known uncommon risks of brain irradiation. We describe 4 cases of RIMG that occurred at our institution and conduct the largest comprehensive review of the literature to characterize RIMGs better. ...
Full textLink to itemCite
Journal ArticlePhys Med Biol · March 7, 2015
Prediction of achievable dose distribution in spine stereotactic body radiation therapy (SBRT) can help in designing high-quality treatment plans to maximally protect spinal cords and to effectively control tumours. Dose distributions at spinal cords are p ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · January 1, 2015
PURPOSE: To identify an optimal margin about the gross target volume (GTV) for stereotactic radiosurgery (SRS) of brain metastases, minimizing toxicity and local recurrence. METHODS AND MATERIALS: Adult patients with 1 to 3 brain metastases less than 4 cm ...
Full textLink to itemCite
Journal ArticleLecture Notes in Computational Vision and Biomechanics · January 1, 2015
Accurate dose predication is critical to spinal stereotactic body radiation therapy (SBRT). It enables radiation oncologists and planners to design treatment plans that maximally protect spinal cord while effectively controlling surrounding tumors. Spinal ...
Full textCite
Journal ArticleSemin Radiat Oncol · October 2014
In almost all patients, malignant glioma recurs following initial treatment with maximal safe resection, conformal radiotherapy, and temozolomide. This review describes the many options for treatment of recurrent malignant gliomas, including reoperation, a ...
Full textLink to itemCite
ConferenceCancer Research · October 1, 2014
AbstractGlioblastoma multiforme (GBM) is the most common and malignant brain tumor. Current standard treatment for GBM following maximum safe resection includes temozolomide (TMZ) with concurrent radiotherap ...
Full textCite
Journal ArticleCancer · April 1, 2014
Stereotactic body radiotherapy (SBRT) involves the treatment of extracranial primary tumors or metastases with a few, high doses of ionizing radiation. In SBRT, tumor kill is maximized and dose to surrounding tissue is minimized, by precise and accurate de ...
Full textLink to itemCite
Journal ArticleTechnol Cancer Res Treat · February 2014
Stereotactic radiosurgery (SRS) has been an effective treatment method for brain tumors; however, few data are available regarding radiation-induced white matter (WM) damage by SRS. In this work, diffusion tensor imaging (DTI) was used to investigate WM ch ...
Full textLink to itemCite
Journal ArticleJ Radiosurg SBRT · 2014
PURPOSE: For patients with primary CNS lymphoma who achieve complete response (CR) after induction methotrexate-based chemotherapy with rituximab, low-dose whole brain radiation therapy (LD-WBRT) appears effective and is well tolerated. For patients who re ...
Link to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · August 1, 2013
PURPOSE: Virtually all patients with malignant glioma (MG) eventually recur. This study evaluates the safety of concurrent stereotactic radiosurgery (SRS) and bevacizumab (BVZ), an antiangiogenic agent, in treatment of recurrent MG. METHODS AND MATERIALS: ...
Full textLink to itemCite
Journal ArticleSurg Oncol Clin N Am · July 2013
In this article, the application of radiotherapy, alone and in combination with surgery and chemotherapy, in the treatment of metastases to the brain (the most common malignant brain lesion), primary malignant gliomas (the most common malignant primary bra ...
Full textLink to itemCite
Journal ArticleMed Phys · June 2013
PURPOSE: Recent trends in SRS use multifocal VMAT plans to simultaneously treat several, distinct targets. Conventional verification often involves low resolution measurements in a single plane, cylinder, or intersecting planes of diodes or ion chambers. T ...
Full textLink to itemCite
Journal ArticleJ Neurooncol · May 2013
Our group has previously published the Diagnosis-Specific Graded Prognostic Assessment (GPA) showing the prognostic factors associated with survival in patients with brain metastases (BM). The purpose of this study is to investigate the relationship of bre ...
Full textLink to itemCite
Journal ArticleFront Oncol · 2013
PURPOSE/OBJECTIVE: While our department is heavily invested in computer-based treatment planning, we historically relied on paper-based charts for management of Radiation Oncology patients. In early 2009, we initiated the process of conversion to an electr ...
Full textLink to itemCite
Journal ArticleCurr Drug Discov Technol · December 2012
Malignant glioma remains a disease with poor prognosis despite recent advances in the multidisciplinary care of this disease. Herein we review the evolution of and recent advances in radiation therapy for malignant glioma that have allowed for more targete ...
Full textLink to itemCite
Journal ArticleMed Phys · November 2012
PURPOSE: The authors present an evidence-based approach to quantify the effects of an array of patient anatomical features of the planning target volumes (PTVs) and organs-at-risk (OARs) and their spatial relationships on the interpatient OAR dose sparing ...
Full textLink to itemCite
Journal ArticleNat Rev Clin Oncol · November 2012
Radiotherapy is an integral treatment for patients with metastatic cancer, although it is usually reserved for palliation of pain, dyspnoea, oedema, bleeding and neurological symptoms. However, the administration of high-precision radiotherapy, termed ster ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · October 1, 2012
PURPOSE: To demonstrate a new three-dimensional (3D) quality assurance (QA) method that provides comprehensive dosimetry verification and facilitates evaluation of the clinical significance of QA data acquired in a phantom. Also to apply the method to inve ...
Full textLink to itemCite
Journal ArticleMed Phys · June 2012
PURPOSE: Volumetric modulated arc therapy (VMAT) enables stereotactic radiosurgery (SRS) treatment for multiple lesions with a single isocenter setup. Dosimetry verification is highly challenging however, and the purpose of this study is to validate this n ...
Full textLink to itemCite
ConferenceMed Phys · June 2012
PURPOSE: To investigate the treatment of multiple brain metastases using stereotactic radiosurgery with single-isocenter volumetric modulated arc therapy (VMAT) compared with conventional multi-isocenter dynamic conformal arc therapy (DCAT) and three-dimen ...
Full textLink to itemCite
Journal ArticleTechnol Cancer Res Treat · June 2012
Involvement of a cranial nerve caries a poor prognosis for many malignancies. Recurrent or residual disease in the trigeminal or facial nerve after primary therapy poses a challenge due to the location of the nerve in the skull base, the proximity to the b ...
Full textLink to itemCite
Journal ArticleJ Natl Compr Canc Netw · June 1, 2012
Despite contemporary surgery, image-guided radiotherapy, and chemotherapy, glioblastoma multiforme (GBM) persists or relapses in nearly all patients, and tumors almost always recur locally. Management of recurrent GBM is variable, but approaches include be ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · April 1, 2012
PURPOSE: Patients with recurrent malignant gliomas treated with stereotactic radiosurgery (SRS) and multiagent systemic therapies were reviewed to determine the effects of patient- and treatment-related factors on survival and toxicity. METHODS AND MATERIA ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · April 1, 2012
PURPOSE: The diagnosis-specific Graded Prognostic Assessment (GPA) was published to clarify prognosis for patients with brain metastases. This study refines the existing Breast-GPA by analyzing a larger cohort and tumor subtype. METHODS AND MATERIALS: A mu ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · March 1, 2012
PURPOSE: We assessed the safety and efficacy of synchronous VEGF and epidermal growth factor receptor (EGFR) blockade with concurrent chemoradiation (CRT) in locally advanced head and neck cancer (HNC). EXPERIMENTAL DESIGN: Newly diagnosed patients with st ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · February 1, 2012
PURPOSE: Our group has previously published the Graded Prognostic Assessment (GPA), a prognostic index for patients with brain metastases. Updates have been published with refinements to create diagnosis-specific Graded Prognostic Assessment indices. The p ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · January 1, 2012
PURPOSE: To determine the safety of the addition of bevacizumab to standard radiation therapy and daily temozolomide for newly diagnosed glioblastoma multiforme (GBM). METHODS AND MATERIALS: A total of 125 patients with newly diagnosed GBM were enrolled in ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · June 15, 2011
PURPOSE: To determine if the addition of bevacizumab to radiation therapy and temozolomide, followed by bevacizumab, temozolomide, and irinotecan, for newly diagnosed glioblastoma patients is safe and effective. EXPERIMENTAL DESIGN: A total of 75 patients ...
Full textLink to itemCite
Journal ArticleJ Natl Compr Canc Netw · April 2011
Glioblastoma, the most common primary malignant brain tumor among adults, is a highly angiogenic and deadly tumor. Angiogenesis in glioblastoma, driven by hypoxia-dependent and independent mechanisms, is primarily mediated by vascular endothelial growth fa ...
Full textLink to itemCite
Journal ArticleAnticancer Agents Med Chem · February 2011
Despite intensive efforts to improve multimodal treatment of brain tumor, survival remains limited. Current therapy consists of a combination of surgery, irradiation and chemotherapy with predisposition to long-term complications. Identifying novel targete ...
Full textLink to itemCite
ConferenceMedical Physics · January 1, 2011
Purpose: To develop a Radiation Treatment Guidelines Ontology (RTGO) that represents the concepts, knowledge, and guidelines in radiation therapy using a formal and computable framework. This ontology will serve as the foundation of a decision support syst ...
Full textCite
Journal ArticleJ Radiosurg SBRT · 2011
Minimizing radiation-induced normal tissue damage in the central nervous system (CNS) is a key objective and primary impetus for stereotactic radiosurgery and radiotherapy. The recently published Quantitative Analysis of Normal Tissue Effects in the Clinic ...
Link to itemCite
Journal ArticleSarcoma · 2011
Primary meningeal rhabdomyosarcoma is a rare primary brain malignancy, with scant case reports. While most reports of primary intracranial rhabdomyosarcoma occur in pediatric patients, a handful of cases in adult patients have been reported in the medical ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · July 1, 2010
Featured Publication
PURPOSE: Controversy endures regarding the optimal treatment of patients with brain metastases (BMs). Debate persists, despite many randomized trials, perhaps because BM patients are a heterogeneous population. The purpose of the present study was to ident ...
Full textLink to itemCite
Journal ArticleJ Neuroophthalmol · June 2010
Because of the success of stereotactic radiosurgery (SRS) in the treatment of cerebral arteriovenous malformations (AVMs), SRS is being applied to the treatment of carotid-cavernous dural arteriovenous fistulas (CCDAVFs) when these lesions are not accessib ...
Full textLink to itemCite
Journal ArticleRadiother Oncol · April 2010
Featured Publication
PURPOSE: To investigate setup discrepancies measured with ExacTrac X-ray 6 degree-of-freedom (6D) and cone-beam computed tomography (CBCT) for patients under treatments of stereotactic body radiation therapy (SBRT). MATERIALS AND METHODS: In this work, pha ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · March 1, 2010
Featured Publication
Dose-volume data for myelopathy in humans treated with radiotherapy (RT) to the spine is reviewed, along with pertinent preclinical data. Using conventional fractionation of 1.8-2 Gy/fraction to the full-thickness cord, the estimated risk of myelopathy is ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · March 1, 2010
Featured Publication
Publications relating radiation toxicity of the optic nerves and chiasm to quantitative dose and dose-volume measures were reviewed. Few studies have adequate data for dose-volume outcome modeling. The risk of toxicity increased markedly at doses >60 Gy at ...
Full textLink to itemCite
Journal ArticleNeuro Oncol · February 2010
Featured Publication
The aim of the study was to determine if biochemical changes indicative of injury, assessed using magnetic resonance spectroscopic imaging (SI), are observed after stereotactic radiosurgery (SRS). The study included patients who underwent SI immediately be ...
Full textLink to itemCite
ConferenceMedical Physics · January 1, 2010
Purpose: A 15–30s Breath Hold (BH) is often used in radiation therapy for breast cancer patients to minimize heart dose, however its effect on tumor oxygenation and radiosensitivity is unknown. The purpose of this study is to utilize published data on the ...
Full textCite
ConferenceMedical Physics · January 1, 2010
Objectives: Intensity modulated arc therapy (IMAT) can potentially be a useful technique for the treatment of multi‐focal intracranial stereotactic radiosurgery (SRS) with a single isocenter setup. This study compares the effects of coplanar and non‐coplan ...
Full textCite
Journal ArticleRadiother Oncol · December 2009
BACKGROUND AND PURPOSE: To compare the residual setup errors measured with ExacTrac X-ray 6 degree-of-freedom (6D) and cone-beam computed tomography (CBCT) for a head phantom and patients receiving intracranial non-invasive fractionated stereotactic radiot ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · December 1, 2009
PURPOSE: This clinical study evaluates the feasibility of using volumetric arc-modulated treatment (VMAT) for spine stereotactic body radiotherapy (SBRT) to achieve highly conformal dose distributions that spare adjacent organs at risk (OAR) with reduced t ...
Full textLink to itemCite
Journal ArticleAm J Clin Oncol · June 2009
OBJECTIVES: Paragangliomas are rare neuroendocrine neoplasms of the head and neck. Treatment strategies include resection, definitive external beam radiation therapy (EBRT), stereotactic radiosurgery (SRS), or observation alone. Due to their rarity and ind ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · May 20, 2009
e13007 Background: Malignant glioma (MG), an incurable primary CNS tumor, is characterized by frequent aberrant activation of EGFR, VEGFR, and PDGFR. This study will determine the MTD and DLT of vandetanib (V), a once-daily, oral selective inhibitor of VEG ...
Link to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · April 1, 2009
Featured Publication
PURPOSE: To describe our experience and clinical strategy for stereotactic body radiotherapy (SBRT) of spinal lesions. METHODS AND MATERIALS: Thirty-two patients with 33 spinal lesions underwent computed tomography-based simulation while free breathing. Gr ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · March 15, 2009
Featured Publication
PURPOSE: A prospective study was performed to formally relate dose-dependent radiologically defined changes in normal brain induced by radiotherapy (RT) to neurocognitive dysfunction in subjects with primary brain tumors. METHODS AND MATERIALS: Adult patie ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · February 1, 2009
PURPOSE: To quantitatively assess the relationship between intensity-modulated radiotherapy (IMRT)-driven sparing of dose to normal tissues located "within" concave targets with heterogeneity in dose delivered to the target and redistribution of dose to no ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · February 1, 2009
Featured Publication
PURPOSES: To quantitatively compare two-dimensional (2D) orthogonal kV with three-dimensional (3D) cone-beam CT (CBCT) for target localization; and to assess intrafraction motion with kV images in patients undergoing stereotactic body radiotherapy (SBRT). ...
Full textLink to itemCite
Journal ArticleRadiat Oncol · January 21, 2009
Featured Publication
BACKGROUND: This study evaluated the dosimetric impact of various treatment techniques as well as collimator leaf width (2.5 vs 5 mm) for three groups of tumors -- spine tumors, brain tumors abutting the brainstem, and liver tumors. These lesions often pre ...
Full textOpen AccessLink to itemCite
Journal ArticleRadiation Oncology · January 21, 2009
Background: This study evaluated the dosimetric impact of various treatment techniques as well as collimator leaf width (2.5 vs 5 mm) for three groups of tumors - spine tumors, brain tumors abutting the brainstem, and liver tumors. These lesions often pres ...
Full textCite
ConferenceMedical Physics · January 1, 2009
Purpose: To investigate localization accuracy for image‐guided frameless stereotactic‐radiosurgery (IG‐SRS) using CBCT 6D image registration and 6D‐couch on Novalis Tx system. Method and Materials: Novalis Tx system is a powerful radiosurgery system featur ...
Full textCite
ConferenceMedical Physics · January 1, 2009
Objectives: To investigate the feasibility of using an intensity modulated arc technique for multi‐focal intracranial stereotactic radiosurgery with a single isocenter setup to significantly decrease the treatment time. Methods: A Novalis Tx linear acceler ...
Full textCite
ConferenceMedical Physics · January 1, 2009
Objectives: To compare localization accuracy using both conventional frame‐based localizers and cone‐beam CT (CBCT) images for stereotactic radiosurgery (SRS). Methods: A SRS geometric phantom was used to verify the localization accuracy based on a SRS loc ...
Full textCite
ConferenceMedical Physics · January 1, 2009
Purpose: Cervical spine (C‐spine) lesions are located more centrally than the rest of the spinal column making the c‐spine an ideal target for the RapidArc therapy technique. In this study, we explore the use of RapidArc to treat c‐spine patients and inves ...
Full textCite
ConferenceMedical Physics · January 1, 2009
Purpose: Volumetric modulated arc treatment (VMAT) reduces treatment time over static beam intensity modulated treatment (IMRT) by delivering IMRT using arcs. This clinical study evaluates the feasibility of using VMAT for spine stereotactic body radiother ...
Full textCite
Journal ArticleSemin Radiat Oncol · October 2008
Featured Publication
The linear-quadratic (LQ) model is widely used to model the effect of total dose and dose per fraction in conventionally fractionated radiotherapy. Much of the data used to generate the model are obtained in vitro at doses well below those used in radiosur ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · May 20, 2008
8094 Background: The risk of developing brain metastases after definitive treatment for locally-advanced non-small cell lung cancer (NSCLC) is approximately 30%-50%. The risk for patients with early-stage disease is less defined. We sought to investigate t ...
Link to itemCite
Journal ArticleJ Clin Oncol · May 20, 2008
2057 Background: Angiogenesis is a hallmark of MG with VEGF as a key regulator. Imatinib mesylate (IM) and hydroxyurea (H) have recently demonstrated promising anti-glioma activity. We attempt to extend the efficacy of IM and H by adding a VEGF receptor in ...
Link to itemCite
Journal ArticleTechnol Cancer Res Treat · April 2008
This report describes the technique and initial experience using cone beam CT (CBCT) for localization of treatment targets in patients undergoing stereotactic body radiation therapy (SBRT). Patients selected for SBRT underwent 3-D or 4-D CT scans in a cust ...
Full textLink to itemCite
Journal ArticleRadiat Res · March 2008
Featured Publication
It is often useful to calculate the concentration profile for a substrate undergoing reaction in the tissue surrounding a capillary. In this paper, we consider a model geometry consisting of a long straight cylinder of tissue surrounding a capillary. Subst ...
Full textLink to itemCite
Journal ArticleBiomark Insights · February 1, 2008
Featured Publication
Tumor hypoxia is associated with adverse outcome in many malignancies. The goal of this study was to determine if elevated expression of carbonic anhydrase IX (CAIX), a biomarker of hypoxia, predicts for recurrence in early-stage cervical cancer. The chart ...
Full textLink to itemCite
ConferenceMedical Physics · January 1, 2008
Purpose: While the advantage of imaging guidance with cone beam CT (CBCT) guided radiosurgery is obvious, the localization accuracy of CBCT guided radiosurgery still remains a concern. This study utilized a geometric phantom with known target positions to ...
Full textCite
ConferenceMedical Physics · January 1, 2008
Purpose: Rind radiosurgery is a highly modulated technique that aims to treat the proliferative disease of ring‐enhancing intracranial lesions, and to reduce the dose to normal brain tissue when compared with conventional radiosurgery. This study aims to q ...
Full textCite
Journal ArticleAnn Ophthalmol (Skokie) · 2008
We report a case of a patient with previously treated follicular thyroid carcinoma who presented with a symptomatic amelanotic choroidal mass with low internal reflectivity and a metastatic lytic skull lesion. A 25-gauge vitrector was used to perform trans ...
Link to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · August 1, 2007
Featured Publication
PURPOSE: To estimate the radiotherapeutic dose equivalence of chemoradiotherapy in head and neck cancer. METHODS: The biologic equivalent dose (BED) of radiotherapy in nine trials of standard and five trials of modified fractionated radiotherapy with or wi ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · July 15, 2007
PURPOSE: To create, on the basis of available data, a mathematical model to describe the tumor stage- and field size-dependent risks/benefits of postoperative radiotherapy (PORT) for non-small-cell lung cancer (NSCLC), and to assess whether this simple mod ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · May 1, 2007
PURPOSE: To investigate the temporal onset of hypoxia following irradiation, and to show how it relates to pulmonary vascular damage, macrophage accumulation, and the production of reactive oxygen species and cytokines. Our previous studies showed that tis ...
Full textLink to itemCite
Journal ArticleGynecol Oncol · March 2007
Featured Publication
PURPOSE: To report our recent experience managing four patients with brain metastases of gestational trophoblastic neoplasia (GTN), coordinating systemic chemotherapy with early neurosurgical intervention or stereotactic radiosurgery and intensive supporti ...
Full textLink to itemCite
ConferenceMedical Physics · January 1, 2007
Purpose: To compare treatment isocenter placement based on OBI 2D kV imaging and OBI 3D‐CBCT imaging for patients undergoing SBRT, and compare the CBCT based isocenter shifts among liver, lung and spine lesions. Material and Methods: 119 SBRT fractions wer ...
Full textCite
Journal ArticleRadiat Oncol · December 22, 2006
Featured Publication
BACKGROUND: Medulloblastoma and other types of tumors that gain access to the cerebrospinal fluid can spread throughout the craniospinal axis. The purpose of this study was to devise a simple multi-compartment kinetic model using established tumor cell gro ...
Full textLink to itemCite
Journal ArticleMed Phys · September 2006
The physical basis and preliminary applications of optical computed tomography (optical-CT) and optical emission computed tomography (optical-ECT) are introduced, as new techniques with potential to provide unique 3D information on a variety of aspects of ...
Full textLink to itemCite
Journal ArticleNeurosurgery · June 2006
OBJECTIVE: Intramedullary spinal cord arteriovenous malformations (AVMs) have an unfavorable natural history that characteristically involves myelopathy secondary to progressive ischemia and/or recurrent hemorrhage. Although some lesions can be managed suc ...
Full textLink to itemCite
Journal ArticleSemin Radiat Oncol · April 2006
Featured Publication
Oligometastases refer to metastases that are limited in number and location and are amenable to regional treatment. The majority of these metastases appear in the brain, lung, liver, and bone. Although the focus of interest in the past within radiation onc ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · February 1, 2006
Featured Publication
PURPOSE: The treatment of early-stage Hodgkin's disease (HD) has evolved from radiotherapy alone (RT) to combined-modality therapy (CMT) because of concerns about late adverse effects from high-dose subtotal nodal irradiation (STNI). However, there is litt ...
Full textLink to itemCite
Journal ArticleMol Cancer Ther · February 2006
Evidence for erythropoietin signaling has been shown in several nonhematopoietic tissues, including many tumor types. Clinically, recombinant erythropoietin treatment of malignancy-related anemia has yet to be definitively associated with any modulation of ...
Full textLink to itemCite
Journal ArticleRadiat Res · February 2006
Featured Publication
Tumor hypoxia is associated with poor clinical outcome in a variety of tumors, including cervical, head/neck and breast cancer. Administration of erythropoietic factors has been suggested as a means of improving tumor oxygenation (pO2). This study randomiz ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · January 15, 2006
Featured Publication
Erythropoietin (Epo) has long been known to be the principal hematopoietic growth factor that regulates cellular proliferation and differentiation along the erythroid lineage. Recent studies have shown that Epo is a pleiotropic cytokine that is proangiogen ...
Full textLink to itemCite
ConferenceMedical Physics · January 1, 2006
Purpose: To develop and assess a technique using cone‐beam CT (CBCT) to localize treatment targets for stereotactic body radiation therapy (SBRT). Material and Methods: Patients selected for SBRT had 3‐D or 4‐D CT simulation with immobilization. GTV, CTV, ...
Full textCite
Journal ArticleBr J Cancer · December 12, 2005
Featured Publication
Tumour hypoxia has been shown to increase mutation rate, angiogenesis, and metastatic potential, and decrease response to conventional therapeutics. Improved tumour oxygenation should translate into increased treatment response. Exogenous recombinant eryth ...
Full textLink to itemCite
Journal ArticleClin Adv Hematol Oncol · December 2005
Featured Publication
The optimal treatment of the patient at high risk for local recurrence of prostate cancer after radical prostatectomy is controversial. Similarly, there is much controversy over how to treat patients with a rising prostate-specific antigen (PSA), but witho ...
Link to itemCite
Journal ArticleCancer Res · October 15, 2005
Tumor-derived glucose-regulated protein 94 (GRP94/gp96) has shown great promise as a tumor vaccine. However, current protein-based approaches require the availability of large quantities of tumor tissue, which are often not possible. In addition, the effic ...
Full textLink to itemCite
ConferenceMedical Physics · January 1, 2005
Purpose: To study radiotherapy (RT)‐induced dose‐dependent functional changes in the human cerebral cortex region using serial [formula omitted] and [formula omitted] PET imaging before and after RT. Method and Materials: Eleven human subjects were enrolle ...
Full textCite
Journal ArticleCancer Res · November 15, 2004
Hypoxia-inducible factor-1alpha (HIF-1alpha) is an important transcriptional factor that is activated when mammalian cells experience hypoxia, a tumor microenvironmental condition that plays pivotal roles in tumor progression and treatment. In this study, ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · July 15, 2004
9530 Background: Erythropoietin (EPO) increases tumor oxygenation in several pre-clinical models. This improvement in oxygenation should lead to enhanced treatment responses. However, EPO has failed to show improved treatment outcomes in 2 recent, randomiz ...
Link to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · July 1, 2004
Featured Publication
PURPOSE: Tumor hypoxia is associated with less effective radiation-mediated cell killing, increased metastatic potential, and poorer prognosis. Transient variations in hypoxia, with characteristic periodicity on the order of 1 to 10 min, have been observed ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · February 15, 2004
PURPOSE: To develop a novel conditionally replicative adenovirus vector that targets telomerase-positive cancer cells. EXPERIMENTAL DESIGN: A telomerase gene-derived promoter was used to control the expression of the E1a gene so that the E1a gene is only e ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · February 1, 2004
Featured Publication
PURPOSE: Models for cell killing and repopulation can provide insight into the efficacy of therapies. Using clinical data on breast cancer recurrence after lumpectomy with or without radiotherapy (L+/-RT) and brain metastases after chemotherapy with or wit ...
Full textLink to itemCite
Journal ArticleCancer Res · October 1, 2003
Featured Publication
Tumor oxygenation is known to be an important predictive/prognostic marker in a variety of tumors, including cervix, head/neck, sarcoma, non-small cell of the lung, and breast. Tumor oxygenation is influenced by many interactions, including oxygen delivery ...
Link to itemCite
Journal ArticleAm J Clin Oncol · April 2003
Featured Publication
Initial treatment for posttransplant lymphoproliferative disorder (PTLD) usually involves discontinuation of immunosuppressants. Anti-CD20 monoclonal antibody and/or antivirals are typically employed for persistent disease. Chemotherapy is generally reserv ...
Full textLink to itemCite
Journal ArticleRadiat Res · March 2003
Featured Publication
Hypoxia imparts radioresistance to tumors, and various approaches have been developed to enhance oxygenation, thereby improving radiosensitivity. This study explores the influence of kinetic and physical factors on substrate metabolism in a tumor model, ba ...
Full textLink to itemCite
Journal ArticleBlood · March 1, 1993
We have investigated the role of plasminogen activator inhibitor 1 (PAI-1) in the regulation of fibrinolysis using a model thrombus composed of thrombin-stimulated platelets, fibrin(ogen), plasminogen, and recombinant tissue-type plasminogen activator. Las ...
Link to itemCite
Conference · December 1, 1990
Styrenic block copolymers (SBC) can serve to toughen and/or compatibilize a broad range of plastics. Included among these plastics are polystyrene, polyolefins, polyphenylene ether, polycarbonate, polyamides and polyesters. Selecting the correct SBC polyme ...
Cite
Journal ArticleElastomerics · October 1, 1988
Impact properties of various thermoplastics can be modified by blending these thermoplastics with styrenic block copolymers and polystyrene-poly(ethylene-co-butylene)-polystyrene (SEBS) block copolymers. Some of the thermoplastics discussed include polyphe ...
Cite
ConferenceASTM Special Technical Publication · December 1, 1987
Mechanical properties of asphalts containing styrenic block copolymers and properties of dense-graded asphalt concrete produced from these binders are presented. Materials studied include unmodified AC-5 and AC-20 asphalts and AC-5 containing 3 and 6% styr ...
Cite
Journal ArticleThromb Haemost · February 29, 1980
Featured Publication
Cytochalasin B alters the structure and functional properties of filamentous actin. Platelet-mediated clot retraction in dilute platelet-rich plasma (PRP) is inhibited progressively at cytochalasin B concentrations of 0.01 mg/ml, 0.05 mg/ml and 0.1 mg/ml. ...
Link to itemCite
Journal ArticleWater Research · January 1, 1980
A mathematical model of heat and mass transfer for a fluid flowing in a hollow cylinder with a tubular biofilm is developed. Results in dimensionless form are presented for mass transfer in isothermal laminar and turbulent flow and for heat transfer and co ...
Full textCite
Journal ArticleJournal of Rheology · January 1, 1979
A Weissenberg rheogoniometer in the oscillatory mode was employed to determine the effect of fibrinolysis and fibrinogen degradation products (FDP) on the development of the dynamic shear moduli in coagulating platelet-free plasma (PFP) and platelet-rich p ...
Full textCite
Journal ArticleMed Dosim
Previous work demonstrated improved dosimetry of single isocenter volumetric modulated arc therapy (VMAT) of multiple intracranial targets when they are located ≤ 4cm from isocenter because of narrower multileaf collimators (MLCs). In follow-up, we sought ...
Full textLink to itemCite
ConferenceMed Dosim
This study aimed to report hippocampal dose from single-fraction stereotactic radiosurgery (SRS) for 4 to 10 brain metastases and determine feasibility of hippocampal-sparing SRS. Patients with 4 to 10 brain metastases receiving single-isocenter, multi-tar ...
Full textLink to itemCite
Journal ArticleMed Dosim
Linac based radiosurgery to multiple metastases is commonly planned with volumetric modulated arc therapy (VMAT) as it effectively achieves high conformality to complex target arrangements. However, as the number of targets increases, VMAT can struggle to ...
Full textLink to itemCite